Oruka Therapeutics, Inc. Interest Expense
Oruka Therapeutics, Inc. (ORKA) reported Interest Expense of $9.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2022-03-14
- Oruka Therapeutics, Inc. interest expense for the quarter ending 2020-12-31 was $0.00.
- Oruka Therapeutics, Inc. interest expense for the quarter ending 2020-09-30 was $2.00K, a 100.00% increase year-over-year.
- Oruka Therapeutics, Inc. interest expense for the quarter ending 2020-06-30 was $3.00K, a 0.00% change year-over-year.
- Oruka Therapeutics, Inc. interest expense for the quarter ending 2020-03-31 was $4.00K, a 33.33% increase year-over-year.
- Oruka Therapeutics, Inc. interest expense for fiscal 2020 was $9.00K, a 28.57% increase from fiscal 2019.
- Oruka Therapeutics, Inc. interest expense for fiscal 2019 was $7.00K, a 12.50% decline from fiscal 2018.
- Oruka Therapeutics, Inc. interest expense for fiscal 2018 was $8.00K, a 33.33% increase from fiscal 2017.
- Oruka Therapeutics, Inc. interest expense for fiscal 2017 was $6.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $2.00K derived: sum of 2 quarters · filed 2022-03-14 | $5.00K derived: sum of 3 quarters · filed 2022-03-14 | $9.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $2.00K 10-Q · filed 2021-11-02 | $5.00K derived: sum of 2 quarters · filed 2021-11-02 | $9.00K 10-Q · filed 2021-11-02 | $9.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $3.00K 10-Q · filed 2021-08-04 | $7.00K 10-Q · filed 2021-08-04 | $7.00K derived: sum of 3 quarters · filed 2021-08-04 | $8.00K derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $4.00K 10-Q · filed 2021-05-11 | $4.00K derived: sum of 2 quarters · filed 2021-05-11 | $5.00K derived: sum of 3 quarters · filed 2021-05-11 | $8.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.00K derived: sum of 2 quarters · filed 2021-03-18 | $4.00K derived: sum of 3 quarters · filed 2021-03-18 | $7.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $1.00K 10-Q · filed 2020-11-02 | $4.00K derived: sum of 2 quarters · filed 2020-11-02 | $7.00K 10-Q · filed 2020-11-02 | $7.00K derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | $3.00K 10-Q · filed 2020-08-05 | $6.00K 10-Q · filed 2020-08-05 | $6.00K derived: sum of 3 quarters · filed 2020-08-05 | $8.00K derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $3.00K 10-Q · filed 2020-05-06 | $3.00K derived: sum of 2 quarters · filed 2020-05-06 | $5.00K derived: sum of 3 quarters · filed 2020-05-06 | $8.00K derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $2.00K derived: sum of 2 quarters · filed 2020-02-18 | $5.00K derived: sum of 3 quarters · filed 2020-02-18 | $8.00K 10-K · filed 2020-02-18 |
| 2018-09-30 | $2.00K 10-Q · filed 2019-11-06 | $5.00K derived: sum of 2 quarters · filed 2019-11-06 | $8.00K 10-Q · filed 2019-11-06 | $8.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $3.00K 10-Q · filed 2019-08-01 | $6.00K 10-Q · filed 2019-08-01 | $6.00K derived: sum of 3 quarters · filed 2019-08-01 | $8.00K derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | $3.00K 10-Q · filed 2019-05-08 | $3.00K derived: sum of 2 quarters · filed 2019-05-08 | $5.00K derived: sum of 3 quarters · filed 2019-05-08 | $7.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.00K derived: sum of 2 quarters · filed 2019-02-27 | $4.00K derived: sum of 3 quarters · filed 2019-02-27 | $6.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | $2.00K 10-Q · filed 2018-11-14 | $4.00K derived: sum of 2 quarters · filed 2018-11-14 | $6.00K 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $2.00K 10-Q · filed 2018-08-09 | $4.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $2.00K 10-Q · filed 2018-05-08 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $1.00K derived: sum of 2 quarters · filed 2017-03-21 | $3.00K derived: sum of 3 quarters · filed 2017-03-21 | $4.00K 10-K · filed 2017-03-21 |
| 2015-09-30 | $1.00K 10-Q · filed 2016-11-14 | $3.00K derived: sum of 2 quarters · filed 2016-11-14 | $4.00K 10-Q · filed 2016-11-14 | $4.00K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $2.00K 10-Q · filed 2016-08-09 | $3.00K 10-Q · filed 2016-08-09 | $3.00K derived: sum of 3 quarters · filed 2016-08-09 | $4.00K derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | $1.00K 10-Q · filed 2016-05-11 | $1.00K derived: sum of 2 quarters · filed 2016-05-11 | $2.00K derived: sum of 3 quarters · filed 2016-05-11 | $3.00K derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $1.00K derived: sum of 2 quarters · filed 2016-03-17 | $2.00K derived: sum of 3 quarters · filed 2016-03-17 | $3.00K 10-K · filed 2016-03-17 |
| 2014-09-30 | $1.00K 10-Q · filed 2015-11-12 | $2.00K derived: sum of 2 quarters · filed 2015-11-12 | $3.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $1.00K 10-Q · filed 2015-08-11 | $2.00K 10-Q · filed 2015-08-11 | ||
| 2014-03-31 | $1.00K 10-Q · filed 2015-05-12 | |||
| 2013-12-31 | $4.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |